These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18567913)

  • 21. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
    Tenorio-Abreu A; Eiros JM; Rodríguez-Molins E; Andaluz D; Bobillo F; Domínguez-Gil M; Ortiz de Lejarazu R
    Rev Esp Quimioter; 2010 Jun; 23(2):76-80. PubMed ID: 20559605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005-2009).
    Mendes RE; Farrell DJ; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):307-11. PubMed ID: 20955916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals.
    Al-Sweih NA; Al-Hubail MA; Rotimi VO
    J Chemother; 2011 Feb; 23(1):13-6. PubMed ID: 21482488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of tigecycline in clinical isolates of multidrug resistant Acinetobacter spp. Comparison of different methods of evaluation].
    Zárate MS; Serruto G; Smayevsky J
    Rev Argent Microbiol; 2010; 42(1):53-6. PubMed ID: 20461296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
    Karageorgopoulos DE; Kelesidis T; Kelesidis I; Falagas ME
    J Antimicrob Chemother; 2008 Jul; 62(1):45-55. PubMed ID: 18436554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009).
    Sader HS; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):223-7. PubMed ID: 21251571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK; Ergin A; Tunçkanat F; Hasçelik G
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of multi-resistant Gram-negative bacilli in Singapore to tigecycline as tested by agar dilution.
    Tan TY; Ng LS
    Ann Acad Med Singap; 2007 Oct; 36(10):807-10. PubMed ID: 17987230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW; Jang TN; Cheng YJ; Hsu GJ; Sun W; Lu CT; Hsueh PR;
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the variability in the susceptibility of Acinetobacter baumannii to tigecycline in the same medium with two methods of quantitative diffusion different commercial].
    Tejero R; Causse M; Moreno M; Solís F; Rodríguez-López F; Casal M
    Rev Esp Quimioter; 2012 Sep; 25(3):189-93. PubMed ID: 22987264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in determining in vitro tigecycline susceptibility according to the agar medium used.
    Leal AL; Buitrago G; Ovalle MV; Cortés JA; Alvarez CA; Larrota J;
    J Chemother; 2010 Apr; 22(2):137-8. PubMed ID: 20435576
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest.
    Pillar CM; Draghi DC; Dowzicky MJ; Sahm DF
    J Clin Microbiol; 2008 Sep; 46(9):2862-7. PubMed ID: 18596149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility testing of unconventional antibiotics against multiresistant Acinetobacter spp. by agar dilution and Vitek 2.
    Tan TY; Ng LS; Poh K
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):357-61. PubMed ID: 17467946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates.
    Piewngam P; Kiratisin P
    Int J Antimicrob Agents; 2014 Nov; 44(5):396-401. PubMed ID: 25442358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii?
    Grandesso S; Sapino B; Amici G; Mazzucato S; Solinas M; Gion M
    New Microbiol; 2014 Oct; 37(4):503-8. PubMed ID: 25387287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan.
    Shakoor S; Khan E; Zafar A; Hasan R
    Chemotherapy; 2010; 56(3):184-9. PubMed ID: 20551633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Thamlikitkul V; Tiengrim S; Tribuddharat C
    J Antimicrob Chemother; 2007 Jul; 60(1):177-8; author reply 178-9. PubMed ID: 17496287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.